Mark As Unread
NIH "$100,000 Start an SUD Startup" Challenge
ABOUT THE GRANT
The NIH "$100,000 Start an SUD Startup" Challenge awards a total of $100,000 in cash prizes (up to $10,000 per winning team) plus intensive non-cash mentorship to early-stage teams developing research ideas in drug use, misuse, or substance use disorder (SUD) that could form the foundation of new biotech startups. Administered annually by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), the challenge is designed to support and accelerate would-be founders before they typically become eligible for traditional research funding, and to eventually contribute new startups to the pool of small businesses competing for NIDA's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants.
The challenge is administered in two stages. In Stage 1, up to 12 winning teams are selected based on a 5-minute video introducing the team and a 4-page written proposal describing the research idea, and each Stage 1 winner receives a non-cash prize of a 6-month product development mentorship from NIDA entrepreneurship experts (including monthly 90-minute lectures, monthly office hours with an assigned mentor, and a series of homework assignments, requiring approximately 25 hours per team member per month). In Stage 2, the teams that successfully complete the mentorship (including all required lectures, exercises, and a final Peer Board Meeting presentation) are each awarded up to $10,000 in cash. Winners are encouraged to use the prize money to develop a minimum viable product, gather customer feedback, assess the feasibility of a science-based small business, and develop key concepts to support a future NIDA SBIR/STTR application.
To qualify, participants must apply as a team of no less than three and no more than five individuals, each at least 18 years old at the time of submission. Each team must identify a Team Leader who is a U.S. citizen or permanent resident and who is responsible for registering, submitting materials, and receiving and distributing prize money on behalf of the team. Non-U.S. citizens and non-permanent residents may participate as team members but are not eligible to receive prize money. The research idea must directly relate to drug use, misuse, or SUD (or a platform technology broadly applicable to those areas), and the team must intend to form (or already be) a U.S.-based startup. Teams need no prior startup experience. Federal employees (of HHS or acting within their federal scope) are not eligible, and SBIR/STTR grantees with currently active grants or applications currently under review cannot participate. Teams that applied to a past challenge and did not win may reapply with the same or a new idea; past winners may reapply only with a new idea. Submissions related to alcohol use disorder or pain will not be accepted.
Tracking grants is our job
Sign up for The Grant Brief to get our latest grants every Tuesday. One email, zero fluff.
NOTES
This is one of the limited grants that are open to businesses in the "idea" stage. Success here does not require any demonstrated traction with your business or business idea. If you're looking for a grant to get your startup idea off the ground, this could be a great one if the industry focus fits your business.
Not the right grant for you?
Other Grants
ACCELERATE Oral Health Grants
Matter Health
ACCELERATE is focused on solutions that have shown progress in improving access, equity, and integration of oral health or overall health, including for underserved populations. As part of ACCELERATE, companies may receive: -Up to $100,000 in non-dilutive funds, which must be matched directly or in-kind by an industry partner -Support to scope the project and drive toward outcomes -Data and analytics support, including claims analysis, outcomes design, ROI modeling, and more -Networking at closed-door and industry events with our ecosystem of partners -Follow-on support after successful pilots, such as further partnership or investment
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers
National Institutes of Health
This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) to engage in high-impact studies that will significantly advance clinical practice and generate knowledge that will fuel transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers will support the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders within well-defined target populations; (2) organizing and delivering optimized mental health services within real world treatment settings; and (3) continuously improving the quality, impact, and durability of optimized interventions and service delivery within diverse care systems. The ALACRITY Centers program is intended to support research that maximizes synergies across various components of the mental health research ecosystem, including new discoveries in clinical research, transformative health care technologies, advances in information science, and new federal and state mechanisms for organizing mental health care.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes
National Institutes of Health
This notice of funding opportunity (NOFO) invites applications designed to examine the efficacy and clinical effectiveness of multimodality digital health technology approaches to the remote management of diabetes.